非小细胞肺癌同步放化疗后肺FDG摄取与放射性肺炎的关联
该研究为临床试验NCT00915005的二次分析,纳入152例接受同步放化疗的非小细胞肺癌患者,评估治疗后肺FDG摄取参数与放射性肺炎严重程度的关系。结果显示治疗后1-6个月PET表现与RP严重程度显著相关(均P<0.05),7-12个月无显著关联(均P>0.05);治疗后1-3个月肺FDG摄取可预测后续≥2级RP(均P<0.05),并给出SUVmax、SUVpeak、SUVmean和GLG的截断值。
要点
- 同步放化疗后1-6个月肺FDG摄取与RP严重程度显著相关。
- 治疗后1-3个月肺FDG摄取可预测后续≥2级RP。
- 预测≥2级RP的截断值:SUVmax 4.54、SUVpeak 3.69、SUVmean 0.78、GLG 2295。
核心结论
- 同步放化疗后前6个月内肺FDG摄取与放射性肺炎严重程度显著相关。
- 治疗后1-3个月肺FDG摄取参数可预测后续≥2级放射性肺炎的发生。
研究设计与样本
- 研究为前瞻性临床试验NCT00915005的二次分析,纳入152例接受同步放化疗的非小细胞肺癌患者。
- 评估治疗后肺FDG摄取变量包括SUVmax、SUVmean、SUVpeak和全局肺糖酵解(GLG;肺SUVmean×肺体积)。
- 放射性肺炎严重程度采用不良事件通用术语标准v3.0评分。
主要发现
- 治疗后1-6个月PET表现与RP严重程度存在显著关联(均P<0.05)。
- 治疗后7-12个月PET表现与RP严重程度无显著关联(均P>0.05)。
- 治疗后1-3个月肺FDG摄取预测后续≥2级RP的截断值:SUVmax 4.54、SUVpeak 3.69、SUVmean 0.78、GLG 2295(均P<0.05)。
关键数值与推荐
- 预测≥2级RP的SUVmax截断值为4.54。
- 预测≥2级RP的SUVpeak截断值为3.69。
- 预测≥2级RP的SUVmean截断值为0.78。
- 预测≥2级RP的GLG截断值为2295。
临床怎么用
- 同步放化疗后1-3个月可参考肺FDG摄取参数(SUVmax、SUVpeak、SUVmean、GLG)及上述截断值识别放射性肺炎高风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Increased uptake of fluorodeoxyglucose (FDG) by lung tissue could reflect inflammatory changes related to radiation pneumonitis (RP). In this secondary analysis of a clinical trial, we examined potential associations between posttreatment lung FDG uptake and RP severity in patients with non-small cell lung cancer (NSCLC) for up to 12 months after concurrent chemoradiation (CRT). METHODS: Subjects were 152 patients with NSCLC who had received concurrent CRT as part of the prospective trial NCT00915005. The following lung FDG variables were evaluated after CRT: maximum, mean, and peak standardized uptake values (SUVmax, SUVmean, SUVpeak) and global lung glycolysis (GLG; lung SUVmean × lung volume). RP severity was scored with the Common Terminology Criteria for Adverse Events v3.0. RESULTS: Significant associations were noted between PET findings and RP severity at 1-6 months (all P < 0.05), but not at 7-12 months after therapy (all P > 0.05). Lung FDG uptake at 1-3 months after treatment predicted later development of grade ≥2 RP (all P < 0.05), with cutoff values as follows: 4.54 for SUVmax, 3.69 for SUVpeak, 0.78 for SUVmean, and 2295 for GLG. CONCLUSIONS: Lung FDG uptake correlated significantly with RP severity during the first 6 months after CRT. The cutoff values seem clinically meaningful for identifying patients at risk of developing RP after such therapy.
引用
- Yue J, McKeever M, Sio TT, et al. Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer. Clin Transl Radiat Oncol. 2017. PMID: 29594201. doi:10.1016/j.ctro.2017.04.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。